News & Events
Sengenics Corporation at Immuno-Oncology Summit 2024
Webinar: Serum Autoantibodies Differentiate Rheumatoid Arthritis Subgroups
Sengenics Corporation Presents at ECM Pharmacology Congress
Sengenics Corporation Announces New Collaboration to Advance Cancer Treatment
Sengenics Corporation Exhibits at Autoimmunity 2024
Sengenics Corporation Announces Key Distributor in China
Sengenics Corporation Launches i-Ome Discovery™ to Advance Immune Biomarker Discovery and Development
Webinar: Building Bioinformatics
Sengenics Corporation Announces New French Distributor
"*" indicates required fields
By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy. I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.
Δ
"*" Indicates required fields By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy. I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.